Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Early improvement with lithium in classic mania and its association with later response.

Machado-Vieira R, Luckenbaugh DA, Soeiro-de-Souza MG, Marca G, Henter ID, Busnello JV, Gattaz WF, Zarate CA Jr.

J Affect Disord. 2013 Jan 10;144(1-2):160-4. doi: 10.1016/j.jad.2012.05.039. Epub 2012 Aug 17.

2.

Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania.

de Sousa RT, Busnello JV, Forlenza OV, Zanetti MV, Soeiro-de-Souza MG, van de Bilt MT, Moreno RA, Zarate CA Jr, Gattaz WF, Machado-Vieira R.

J Psychiatr Res. 2012 Dec;46(12):1564-8. doi: 10.1016/j.jpsychires.2012.08.011. Epub 2012 Sep 20.

3.

Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.

Kemp DE, Johnson E, Wang WV, Tohen M, Calabrese JR.

J Clin Psychiatry. 2011 Sep;72(9):1236-41. doi: 10.4088/JCP.09m05874yel. Epub 2011 Mar 8.

PMID:
21457677
4.

Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.

Katagiri H, Takita Y, Tohen M, Higuchi T, Kanba S, Takahashi M.

Curr Med Res Opin. 2012 May;28(5):701-13. doi: 10.1185/03007995.2012.666961. Epub 2012 Apr 10.

PMID:
22356118
5.

Post-acute effectiveness of lithium in pediatric bipolar I disorder.

Findling RL, Kafantaris V, Pavuluri M, McNamara NK, Frazier JA, Sikich L, Kowatch R, Rowles BM, Clemons TE, Taylor-Zapata P.

J Child Adolesc Psychopharmacol. 2013 Mar;23(2):80-90. doi: 10.1089/cap.2012.0063.

6.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
7.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14. Epub 2007 Mar 27.

PMID:
17391773
8.
9.

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Tohen M, Chengappa KN, Suppes T, Zarate CA Jr, Calabrese JR, Bowden CL, Sachs GS, Kupfer DJ, Baker RW, Risser RC, Keeter EL, Feldman PD, Tollefson GD, Breier A.

Arch Gen Psychiatry. 2002 Jan;59(1):62-9.

PMID:
11779284
10.

Valproate or olanzapine add-on to lithium: an 8-week, randomized, open-label study in Italian patients with a manic relapse.

Maina G, Albert U, Salvi V, Mancini M, Bogetto F.

J Affect Disord. 2007 Apr;99(1-3):247-51. Epub 2006 Oct 23.

PMID:
17056122
11.

Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study.

de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO, Forlenza OV, Gattaz WF, Machado-Vieira R.

Neurosci Lett. 2011 Apr 20;494(1):54-6. doi: 10.1016/j.neulet.2011.02.054. Epub 2011 Mar 6.

PMID:
21362460
12.
13.

Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.

Bowden CL, Mosolov S, Hranov L, Chen E, Habil H, Kongsakon R, Manfredi R, Lin HN.

Int Clin Psychopharmacol. 2010 Mar;25(2):60-7. doi: 10.1097/YIC.0b013e328333ac1b.

PMID:
20101186
14.

Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.

Szegedi A, Calabrese JR, Stet L, Mackle M, Zhao J, Panagides J; Apollo Study Group.

J Clin Psychopharmacol. 2012 Feb;32(1):46-55. doi: 10.1097/JCP.0b013e31823f872f.

PMID:
22198448
15.

Early improvement as a predictor of acute treatment outcome in manic or mixed episodes in bipolar-1 disorder: a pooled, post hoc analysis from the asenapine development program.

Szegedi A, Zhao J, McIntyre RS.

J Affect Disord. 2013 Sep 25;150(3):745-52. doi: 10.1016/j.jad.2013.01.024. Epub 2013 Mar 6.

PMID:
23473546
16.
17.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63. Epub 2007 Mar 26.

PMID:
17383736
18.

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

Vieta E, T'joen C, McQuade RD, Carson WH Jr, Marcus RN, Sanchez R, Owen R, Nameche L.

Am J Psychiatry. 2008 Oct;165(10):1316-25. doi: 10.1176/appi.ajp.2008.07101560. Epub 2008 Apr 1.

PMID:
18381903
19.

Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.

Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.

J Clin Psychiatry. 2012 Nov;73(11):1412-9. doi: 10.4088/JCP.11m07388.

PMID:
23218157
20.

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.

Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.

J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. Erratum in: J Clin Psychiatry. 2011 Aug;72(8):1157. J Clin Psychiatry. 2010 Jan;71(1):93.

PMID:
19778495

Supplemental Content

Support Center